This Solicitation opportunity from Department Of Defense was posted on May 19, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
SODIUM CHLORIDE INJ
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Sodium Chloride Injection in 10 mL disposable syringes, preservative-free and latex-free, is being procured under solicitation SPE2DP-26-T-3479 with a requirement for 30 packages per unit of issue (PG), each containing 30 syringes. The item is identified by NSN 6505-01-595-5160 and must be supplied by AmerisourceBergen Drug Corp, part number 106346, with a non-extendable shelf life of 24 months as mandated by RS016 under the DLA Master List of Technical and Quality Requirements. Packaging must be commercial and compliant with Medical Marking Standard No. 1 (MMS No. 1), which supersedes MIL-STD-129 for medical acquisitions, requiring proper labeling of lot numbers, expiration dates, FDA-regulated information, and unit of issue. All units must be sealed in protective containers and packed in commercial shipping containers suitable for safe transport by common carrier at the lowest cost to the destination, with palletization adhering to RP001. The material is non-hazardous per FED-STD-313 and must be packaged in accordance with ASTM D3951 unless overridden by DLA requirements. The contract specifies FOB destination delivery with inspection and acceptance occurring at the delivery point, and delivery must occur within five days after order placement to the consignee at Rose Barracks, Vilseck, Germany. All packaging and marking must be compliant with MMS No. 1, available on the DLA website, and barcoding must support logistics automation and traceability. The product is regulated by the FDA, requiring a referral in EBS to confirm compliance and supplier details. The contract is a fixed-price type with zero variance allowed in quantity, and payment must be submitted electronically via Wide Area WorkFlow. The solicitation incorporates numerous FAR and DFARS clauses related to cybersecurity, safeguarding controlled information, whistleblower protections, prohibition on covered telecommunications equipment, and compliance with DOD-specific supply chain and packaging rules. Suppliers must hold a valid UEI and CAGE code, represent their small business status accurately via SAM.gov, and comply with all applicable regulations including those governing former DoD officials, hazardous materials, and export control. Proposals must be submitted electronically through DIBBS by May 26, 2026, with no hard copies accepted
General Info
Agency
NAICS
Place of Performance
USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
SODIUM CHLORIDE INJECTION.
10 ML DISP SYRINGE, PRES.FREE
. LATEX FREE, 30 SYRINGES PER TRAY
. U/I "PG" (30'S)
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. . 1 PG = 30 EA
SPE2DP-26-T-3479
SECTION B
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N 106346
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016433449 0001 PG 30.000
NSN/MATERIAL:6505015955160
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W81X9C
0002 CS BN CO A DISTRIBUTI
ROSE BARRACKS BLDG 728 AWCF SSF
SUDLAGER STRASSE
VILSECK 92249
DE
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
SPE2DP-26-T-3479
SECTION B
PR: 7016433449 PRLI: 0001 CONT’D
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
W81X9C
0002 CS BN CO A DISTRIBUTI
ROSE BARRACKS BLDG 728 AWCF SSF
SUDLAGER STRASSE
VILSECK 92249
DE
MARKFOR
W81X9C
0002 CS BN CO A DISTRIBUTI
ROSE BARRACKS BLDG 728 AWCF SSF
SUDLAGER STRASSE
VILSECK 92249
DE
M/F: (TCN) W81X9C61100152
RDD: 121
PROJ: 9GU TP 1
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A01 DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:04/23/2026
SPE2DP-26-T-3479 NSN/Part Number: 6505-01-595-5160 Quantity: 30 PG Purchase Request: 7016433449QTY: 30 Delivery: 5 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS